Managing severe and chronic non-cancer pain without opioids imt.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from imt.ie Daily Mail and Mail on Sunday newspapers.
Just 1 vaccine dose may protect recovered COVID patients from new infection
Recovered COVID-19 patients given a single dose of a currently authorized mRNA vaccine had a robust immune response equal to or exceeding that reached by their coronavirus-naïve peers after the second dose, according to a non–peer reviewed study published yesterday on the medRxiv preprint server.
Currently, the recommended dosing schedule for the two authorized mRNA vaccines, manufactured by Pfizer/BioNTech and Moderna, is two doses given 3 or 4 weeks apart. But the study researchers at Mount Sinai s Icahn School of Medicine say their findings suggest that the current policy could be amended to include only one dose in recovered coronavirus patients, sparing them from side effects and freeing up urgently needed doses.
E-Mail
New research shows that a majority of European anaesthesiologists and intensive care specialists believe that precious intensive care (ICU) capacity should be shared between nations during international emergencies such as the COVID-19 pandemic, allowing countries with excess capacity to help those that are being overwhelmed at any particular moment.
The study is published in the
European Journal of Anaesthesiology (the official journal of the European Society of Anaesthesiology and Intensive Care [ESAIC]), and is co-authored by Dr Elisabeth Adam, University Hospital Frankfurt, Germany; Professor Kai Zacharowski, President of ESAIC and also of University Hospital Frankfurt, Germany; Professor Stefan De Hert, Immediate Past President of ESAIC and University Hospital Ghent, Belgium, and colleagues.